Thermo Fisher Scientific (TMO) Assets Average (2009 - 2026)

Thermo Fisher Scientific has disclosed Assets Average across 18 years of filings, most recently posting $111.8 billion for Q1 2026.

• Quarterly Assets Average rose 13.88% year-over-year to $111.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.8 billion (up 13.88% YoY) and the FY2025 annual result came in at $103.8 billion, up 5.93% from the prior year.
• Assets Average advanced to $111.8 billion in Q1 2026, from $106.7 billion in the prior quarter.
• Over five years, Assets Average peaked at $111.8 billion in Q1 2026 and troughed at $90.6 billion in Q4 2022.
• A 5-year average of $98.0 billion and a median of $97.9 billion in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average surged 39.18% — and 2025, when it gained 0.28%.
• Tracing TMO's Assets Average over 5 years: stood at $93.8 billion in 2022, then rose by 4.31% to $97.9 billion in 2023, then gained by 0.97% to $98.8 billion in 2024, then rose by 7.93% to $106.7 billion in 2025, then advanced by 4.81% to $111.8 billion in 2026.
• Business Quant data shows TMO's Assets Average at $111.8 billion in Q1 2026, $106.7 billion in Q4 2025, and $102.1 billion in Q3 2025.